EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor‐blinded, add‐on, randomized, controlled clinical trial

Maryam Sadat Sadati, Nazafarin Yazdanpanah, Reza Shahriarirad iD, Rojan Javaheri, Mohammad Mahdi Parvizi iD

Journal of Cosmetic Dermatology · 2023

DOI: 10.1111/jocd.15785 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Maryam Sadat Sadati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Metformin, Acne Vulgaris. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Insulin‐like growth factor 1 (IGF‐1) plays a role in the pathogenesis of acne vulgaris. Metformin can reduce IGF‐1 levels and insulin resistance, so it may be useful in treating acne.

Objective

This study compared the efficacy of metformin and doxycycline in treating patients with acne vulgaris.

Methods

In this assessor‐blind, add‐on, randomized controlled clinical trial, we enrolled 40 patients with moderate acne vulgaris aged 15–40 and randomly divided them into two groups. For two months, the first group received doxycycline 100 mg capsules daily, and the second received metformin 500 mg tablets twice daily. The patients in both groups were adminitered to apply a fingertip (fourth finger) of 5% benzoyl peroxide gel (Pangel®) topically every night over the lesions, and to wash it off after 30 min. Patients were evaluated using the Global Acne Grading System (GAGS) score, Investigator Global Assessment for Acne (IGA) score, Cardiff Acne Disability Index (CADI), Total Acne Lesion Count (TLC), and the number of inflammatory and noninflammatory lesions.

Results

By the end of the study, the GAGS, IGA, CADI, and TLC scores and the number of inflammatory and noninflammatory lesions decreased significantly in both groups ( p < 0.001), with no significant difference between the two groups ( p > 0.05).

Conclusion

This trial indicates equal efficacy of doxycycline and metformin in reducing acne vulgaris severity, with doxycycline performing better in reducing lesions of the inflammatory type. Confirmatory or equivalence clinical trials should be performed to confirm our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminAcne VulgarisHumansDoxycyclineInsulin-Like Growth Factor IImmunoglobulin ATreatment OutcomeGelsDouble-Blind Method

Stichwörter der Autor:innen

acne vulgarisdermatologydoxycyclinemetforminquality of life

Substanzen

DoxycyclineInsulin-Like Growth Factor IMetforminImmunoglobulin AGels

Autor:innen und Institutionen

  • Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Reza Shahriarirad, Mohammad Mahdi Parvizi

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Sadati, M. S., Yazdanpanah, N., Shahriarirad, R., Javaheri, R., & Parvizi, M. M. (2023). Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor‐blinded, add‐on, randomized, controlled clinical trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15785

Vancouver

Sadati MS, Yazdanpanah N, Shahriarirad R, Javaheri R, Parvizi MM. Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor‐blinded, add‐on, randomized, controlled clinical trial. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15785

BibTeX
@article{Sadati2023,
  author = {Sadati, Maryam Sadat and Yazdanpanah, Nazafarin and Shahriarirad, Reza and Javaheri, Rojan and Parvizi, Mohammad Mahdi},
  title = {Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor‐blinded, add‐on, randomized, controlled clinical trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2023},
  doi = {10.1111/jocd.15785}
}
Kostenlos starten →